NIAID-Funded Adjuvant Improves Typhoid Vaccine Candidate in Animal Studies

An investigational typhoid vaccine containing a component developed with NIAID funding may overcome some of the shortcomings of available typhoid vaccines, according to a paper published in the journal Vaccine in June.

Vaccines, Free Full-Text

Vaccines, Free Full-Text

Intestinal helminth infection impairs oral and parenteral vaccine

Vaccine Supply Chain Improvements Could Pave the Way to Profitability

Controlled Human Infection Models To Accelerate Vaccine

The find of COVID-19 vaccine: Challenges and opportunities

Vaccines platforms and COVID-19: what you need to know

The impact of human vaccines on bacterial antimicrobial resistance

Frontiers U-Omp19 from Brucella abortus Is a Useful Adjuvant for

Nanocarrier vaccines for SARS-CoV-2 - ScienceDirect

Accelerating Next-Generation Vaccine Development for Global

Vaccines, Free Full-Text

Global Innovations (International Cooperation

News - VaccineNation